Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Serrano Villar, Sergio ^a   Pérez Elías, María Jesús ^a   Dronda, Fernando ^a   Casado, José Luis ^a   Moreno, Ana ^a   Royuela, Ana ^a   Pérez Molina, José Antonio ^a   Sainz, Talia ^b   Navas, Enrique ^a   Hermida, José Manuel ^a   Quereda, Carmen ^a   Moreno, Santiago ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; MORTALITY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE; TIME TO TREATMENT; TREATMENT DURATION; VIRUS INHIBITION; COMPLICATION; HIV INFECTIONS; IMMUNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM; RISK; VIROLOGY;

ADULT; ANTI-HIV AGENTS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CD4-CD8 RATIO; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PROSPECTIVE STUDIES; RISK; ROC CURVE;

EID: 84900412744     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085798     Document Type: Article

References (38)

1. Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, et al. (2011) Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 53: 1120-1126. Available: http://www.ncbi.nlm.nih.gov/pubmed/21998278. Accessed 20 April 2013.
2. Hsue P, Hunt P, Schnell A, Kalapus SC, Hoh R, et al. (2009) Role of Viral Replication, Antiretroviral Therapy, and Immunodeficiency in HIV- Associated Atherosclerosis Priscilla. AIDS 23: 1059-1067. Available: http://www.ncbi.nlm. nih.gov/pmc/articles/PMC2691772/. Accessed 5 August 2010.
3. Seaberg EC, Muñoz A, Lu M, Detels R, Margolick JB, et al. (2005) Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 19: 953-960. Available: http://www.ncbi.nlm.nih.gov/pubmed/15905677. Accessed 27 October 2013.
4. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, et al. (2005) Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 165: 1179-1184. Available: http://www.ncbi.nlm.nih.gov/pubmed/15911733. Accessed 27 October 2013.
5. Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, et al. (2007) Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study. Arch Intern Med 167: 2213-2219. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3189482&tool= pmcentrez&rendertype=abstract. Accessed 27 October 2013.
6. Deeks SG, Tracy R, Douek DC (2013) Systemic Effects of Inflammation on Health during Chronic HIV Infection. Immunity 39: 633-645. Available: http://linkinghub.elsevier.com/retrieve/pii/S1074761313004354. Accessed 18 October 2013.
7. Hogg R, Lima V, Sterne J, Grabar S (2008) Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372: 293-299. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211967/?tool=pubmed. Accessed 27 August 2013.
8. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, et al. (2007) Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 146: 87-95. (Pubitemid 351640011)
9. Stephan C, Hill A, Xi N, van Delft Y, Moecklinghoff C (2012) Research letter: is monitoring for CD4 counts still needed for the management of patients with long-term HIV RNA suppression? J Acquir Immune Defic Syndr 61: e73-5. Available: http://www.ncbi.nlm.nih.gov/pubmed/23183153. Accessed 27 October 2013.
10. Deeks SG, Verdin E, McCune JM (2012) Immunosenescence and HIV. Curr Opin Immunol 24: 501-506. Available: http://www.ncbi.nlm.nih.gov/pubmed/22658763. Accessed 24 September 2013.
11. Phillips AN, Neaton J, Lundgren JD (2008) The role of HIV in serious diseases other than AIDS. AIDS 22: 2409-2418. Available: http://www.ncbi.nlm. nih.gov/pmc/articles/PMC2679976/. Accessed 22 October 2013.
12. Dock JN, Effros RB (2011) Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence. Aging Dis 2: 382-397. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3269814&tool=pmcentrez&rendertype=abstract. Accessed 18 October 2013.
13. Appay V, Sauce D (2008) Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 214: 231-241. (Pubitemid 351160160)
14. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371. Available: http://www.ncbi.nlm.nih.gov/ pubmed/17115046. Accessed 27 October 2013.
15. Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, et al. (2009) HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 15: 893-900. Available: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2859814/?tool=pubmed. Accessed 21 October 2013.
16. Hunt P, Martin JN, Sinclair E, Epling L, Teague J, et al. (2011) Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis 203: 1474-1483. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3080892&tool=pmcentrez&rendertype=abstract. Accessed 11 May 2013.
17. Hadrup SR, Strindhall J, Køllgaard T, Johansson B, Pawelec G, et al. (2006) Longitudinal Studies of Clonally Expanded CD8 T Cells Reveal a Repertoire Shrinkage Predicting Mortality and an Increased Number of Dysfunctional Cytomegalovirus-Specific T Cells in the Very Elderly. J Immunol 176: 2645-2653. Available: http://www.jimmunol.org/content/176/4/2645.short. Accessed 28 August 2013.
18. Wikby A, Johansson B, Ferguson F, Olsson J (1994) Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study. Exp Gerontol 29: 531-541. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 7828662. Accessed 27 October 2013.
19. Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG (1998) Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev 102: 187-198. (Pubitemid 28353538)
20. Wikby A, Ferguson F, Forsey R, Thompson J, Strindhall J, et al. (2005) An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci 60: 556-565. (Pubitemid 40847916)
21. Serrano-Villar S, Gutiérrez C, Vallejo A, Hernández-Novoa B, Díaz L, et al. (2013) The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. J Infect 66: 57-66. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 23046968. Accessed 17 July 2013.
22. Sainz T, Serrano-Villar S, Díaz L, González-Tomé MI, Gurbindo MD, et al. (2013) The CD4/CD8 Ratio as a Marker T-cell Activation, Senescence and Activation/Exhaustion in Treated HIV-Infected Children and Young Adults. AIDS 27: 1513-1516. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 23435292. Accessed 28 February 2013.
23. Serrano-Villar S, Moreno S, Fuentes-Ferrer M, Sánchez-Marcos C, Avila M, et al. (2014) The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery. HIV Med 15: 40-49. Available: http://www.ncbi.nlm.nih. gov/pubmed/24007533. Accessed 10 December 2013.
24. Lo J, Abbara S, Shturman L, Soni A, Wei J, et al. (2010) Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 24: 243-253. Available: http://www.ncbi.nlm.nih.gov/pubmed/19996940. Accessed 30 May 2011.
25. Clifford GM, Rickenbach M, Lise M, Dal Maso L, Battegay M, et al. (2009) Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood 113: 5737-5742. Available: http://www.ncbi.nlm.nih.gov/pubmed/19336755. Accessed 13 May 2013.
26. Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, et al. (2009) Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 27: 884-890. Available: http://www.ncbi.nlm.nih.gov/pubmed/19114688. Accessed 27 October 2013.
27. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, et al. (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169. Available: http://www.ncbi.nlm.nih.gov/pubmed/14581387. Accessed 18 October 2013.
28. Levey AS, Eckardt K-U, Tsukamoto Y, Levin A, Coresh J, et al. (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089-2100. Available: http://www.ncbi.nlm.nih.gov/pubmed/15882252. Accessed 24 October 2013.
29. Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, et al. (2008) Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 148: 728-736. Available: http://www.ncbi.nlm.nih.gov/pubmed/18490686. Accessed 27 October 2013.
30. Baker J V, Peng G, Rapkin J, Abrams DI, Silverberg MJ, et al. (2008) CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS 22: 841-848. Available: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3618460&tool=pmcentrez&rendertype=abstract. Accessed 27 October 2013.
31. Grund B, Peng G, Gibert CL, Hoy JF, Isaksson RL, et al. (2009) Continuous antiretroviral therapy decreases bone mineral density. AIDS 23: 1519-1529. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 2748675&tool=pmcentrez&rendertype=abstract. Accessed 27 October 2013.
32. Hsue P, Lo JC, Franklin A, Bolger AF, Martin JN, et al. (2004) Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 109: 1603-1608. Available: http://www.ncbi.nlm.nih.gov/pubmed/15023877. Accessed 29 May 2013.
33. Taylor JM, Fahey JL, Detels R, Giorgi J V (1989) CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr 2: 114-124. Available: http://www.ncbi.nlm.nih.gov/ pubmed/2495346. Accessed 27 October 2013.
34. Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett a R, et al. (2011) T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis 203: 452-463. Available: http://www. pubmedcentral.nih.gov/articlerender.fcgi?artid=3071219&tool= pmcentrez&rendertype = abstract. Accessed 10 April 2013.
35. Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B (1995) Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A Biol Sci Med Sci 50: B378-B382.
36. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA (1995) CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 95: 2061-2066. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 295794&tool=pmcentrez&rendertype=abstract. Accessed 8 August 2013.
37. Li T, Wu N, Dai Y, Qiu Z, Han Y, et al. (2011) Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy. Clin Infect Dis 53: 944-951. Available: http://www.ncbi.nlm.nih.gov/pubmed/21960716. Accessed 26 October 2013.
38. Devitt E, Rodríguez JM, Pozniak A (2013) CD4 but not CD4:CD8 ratio recovery after 14 years successful HIV suppression. 20th Conference on Retrovirus and Opportunistic Infections. Abstract #311. March 3, 2013. Atlanta, GE.